Translate to...

Stent maker Sahajanand to sell 30% stake, eyes $300 mn valuation

Stent maker Sahajanand to sell 30% stake, eyes $300 mn valuation
Established in 1998, SMT develops and manufactures cardiac products that are sold in 75 countries. Its portfolio includes coronary stents (drug-eluting and bare-metal), renal stents, angioplasty balloon catheters and other cardiac accessories.